No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ABT240719C92000
- 12.09
- -0.31-2.50%
15min DelayClose Jul 18 15:59 ET
12.09High12.09Low
12.09Open12.40Pre Close25 Volume25 Open Interest92.00Strike Price30.23KTurnover0.00%IV4.02%PremiumJul 19, 2024Expiry Date8.07Intrinsic Value100Multiplier0DDays to Expiry4.02Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma12.47Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Abbott Labs Lifts FY24 Outlook After 2Q Sales Rise
By Dean Seal Abbott Laboratories raised its full-year earnings guidance after reporting sales gains in the second quarter from its nutrition and medical devices segments. The Abbott Park, Ill.-based
BTIG Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $135
BTIG analyst Marie Thibault maintains $Abbott Laboratories(ABT.US)$ with a buy rating, and maintains the target price at $135.According to TipRanks data, the analyst has a success rate of 31.7% and
Maintained Buy Rating for Abbott Laboratories on Strong Financials and Growth Prospects
Dow Plunges Over 500 Points Following Unexpected Surge In US Jobless Claims
The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index moved to the "Neutral" zone on Thursday.U.S. stocks closed lower on Thursday, with the Dow Jones
TD Cowen Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $130
TD Cowen analyst Josh Jennings maintains $Abbott Laboratories(ABT.US)$ with a buy rating, and maintains the target price at $130.According to TipRanks data, the analyst has a success rate of 53.1%
Buy Rating Affirmed on Abbott Laboratories Amid Strong Q2 Results and Raised 2024 Guidance
Comments
The earnings season is picking up speed, and this mid-July, we're about to get updates from some of the biggest names across various industries. Expect to hear from large banks, healthcare companies, airlines, and some of the tech and telecom giants that we all know.
The season started off last Friday with $JPMorgan(JPM.US$ , $Wells Fargo & Co(WFC.US$ , and $Wells Fargo & Co(WFC.US$ sharing their numbers. They all did bett...
The season started off last Friday with $JPMorgan(JPM.US$ , $Wells Fargo & Co(WFC.US$ , and $Wells Fargo & Co(WFC.US$ sharing their numbers. They all did bett...
+3
23
$Abbott Laboratories(ABT.US$
The stock has break below the support 101.56. Looks bearish. Next support is 100.64.
The stock has break below the support 101.56. Looks bearish. Next support is 100.64.
1
$Abbott Laboratories(ABT.US$
Bearish engulfing pattern appears in the chart. This stock has turned bearish. Next support is 101.56.
Bearish engulfing pattern appears in the chart. This stock has turned bearish. Next support is 101.56.
2
Morning Movers
Gapping up
$United Airlines(UAL.US$ stock rose 5.2% after the carrier forecast stronger-than-expected earnings in the current quarter and reported a narrower-than-expected loss in the first quarter, buoyed by robust demand for travel.
$Abbott Laboratories(ABT.US$ stock increased by 1.6% after the company surpassed quarterly profit expectations and raised the lower end of its earnings forecast, with strong dem...
Gapping up
$United Airlines(UAL.US$ stock rose 5.2% after the carrier forecast stronger-than-expected earnings in the current quarter and reported a narrower-than-expected loss in the first quarter, buoyed by robust demand for travel.
$Abbott Laboratories(ABT.US$ stock increased by 1.6% after the company surpassed quarterly profit expectations and raised the lower end of its earnings forecast, with strong dem...
31
Read more